Takeda Pharmaceutical Company Limited v. Teva Pharmaceuticals USA, Inc.
1:16-cv-00246
Overview
Case Number
1:16-cv-00246
Filing Date
2016-04-08
Status
Litigation filed
Court
District Court, D. Delaware
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. Delaware
Presiding Judge
Leonard Philip Stark
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd, Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1910188.) - filed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc.. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(nmb) (Entered: 04/08/2016)
2016-04-08
1
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 04/08/2016)
2016-04-08
1
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/2/2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/2/2018. (nmb) (Entered: 04/08/2016)
2016-04-08
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,328,994 B1; 7,431,942 B2; 7,875,292 B2; 7,399,485 B1. (nmb) (Entered: 04/08/2016)
2016-04-08
1
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Takeda Pharmaceutical Company Limited. (nmb) (Entered: 04/08/2016)
2016-04-08
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda America Holdings, Inc. for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc.. (nmb) (Entered: 04/08/2016)
2016-04-08
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda America Holdings, Inc., Corporate Parent Takeda Pharmaceuticals U.S.A., Inc. for Takeda Pharmaceuticals America, Inc. filed by Takeda Pharmaceuticals America, Inc.. (nmb) (Entered: 04/08/2016)
2016-04-08
1
Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Ltd on 4/8/2016; Teva Pharmaceuticals USA, Inc. on 4/8/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmb)
2016-04-08
1
No Actions
Summons Issued
2016-04-08
1
No Actions
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
2016-04-13
1
No Actions
Case Assigned/Reassigned
2016-04-13
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Eric J. Lobenfeld, Arlene L. Chow, Takashi Okuda, Peter H. Noh and Nitya Anand - filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Noreika, Maryellen) (Entered: 05/03/2016)
2016-05-03
1
SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Eric J. Lobenfeld, Arlene L. Chow, Takashi Okuda, Peter H. Noh and Nitya Anand filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 5/3/16. (ntl)
2016-05-03
1
No Actions
SO ORDERED
2016-05-03
1
No Actions
Pro Hac Vice Attorney Peter H. Noh for Takeda Pharmaceuticals America, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cna)
2016-05-05
1
No Actions
Add Attorneys - PHV only
2016-05-05
1
No Actions
Pro Hac Vice Attorney Eric J. Lobenfeld for Takeda Pharmaceuticals America, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
2016-05-05
1
No Actions
Add Attorneys - PHV only
2016-05-09
1
No Actions
Pro Hac Vice Attorney Arlene L. Chow for Takeda Pharmaceuticals America, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (klc)
2016-05-09
1
No Actions
Add Attorneys - PHV only
2016-05-12
1
No Actions
Pro Hac Vice Attorney Takashi Okuda for Takeda Pharmaceuticals America, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cna)
2016-05-12
1
No Actions
SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc.. Teva Pharmaceuticals USA, Inc. served on 5/12/2016, answer due 6/2/2016. (Noreika, Maryellen) (Entered: 05/13/2016)
2016-05-13
1
STIPULATION of Dismissal as to Defendant Teva Pharmaceutical Industries Ltd. and Amendment of Caption by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Noreika, Maryellen) (Entered: 05/13/2016)
2016-05-13
1
~Util - Add and Terminate Parties AND SO ORDERED
2016-05-16
1
No Actions
SO ORDERED, re 10 Stipulation of Dismissal -- Teva Pharmaceutical Industries Ltd terminated. Signed by Judge Leonard P. Stark on 5/16/16. (ntl)
2016-05-16
1
No Actions
Add Attorneys - PHV only
2016-05-17
1
No Actions
Pro Hac Vice Attorney Nitya Anand for Takeda Pharmaceuticals America, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (klc)
2016-05-17
1
No Actions
ANSWER to 1 Complaint,, COUNTERCLAIM against Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 06/02/2016)
2016-06-02
1
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 06/02/2016)
2016-06-02
1
ANSWER to 11 Answer to Complaint, Counterclaim by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Noreika, Maryellen) (Entered: 06/27/2016)
2016-06-27
1
MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi, Lynn M. Ulrich, and John R. McNair - filed by Teva Pharmaceutical Industries Ltd, Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 07/13/2016)
2016-07-13
1
SO ORDERED
2016-07-15
1
No Actions
SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi, Lynn M. Ulrich, and John R. McNair filed by Teva Pharmaceutical Industries Ltd, Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 7/15/16. (ntl)
2016-07-15
1
No Actions
Add Attorneys - PHV only
2016-07-20
1
No Actions
Pro Hac Vice Attorney Lynn M. Ulrich,John R. McNair for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
2016-07-20
1
No Actions
ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than September 2, 2016. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 8/19/16. (ntl) (Entered: 08/19/2016)
2016-08-19
1
Order
2016-08-19
1
No Actions
NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s First Request for Production to Plaintiffs Nos. 1-2 filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 09/01/2016)
2016-09-01
1
PROPOSED ORDER // Scheduling Order by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Cover Letter)(Noreika, Maryellen) (Entered: 09/02/2016)
2016-09-02
1
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 6/19/2017. Status Report due by 7/17/2017. Claim Construction Opening Brief due by 12/20/2016. Claim Construction Answering Brief due by 2/24/2017. A Markman Hearing is set for 3/27/2017 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 1/29/2018. A Final Pretrial Conference is set for 2/9/2018 at 11:30 AM in Courtroom 6B before Judge Leonard P. Stark. A 3-day Bench Trial is set for 2/20/2018 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 9/15/16. (ntl) (Entered: 09/19/2016)
2016-09-19
1
CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (dlk)
2016-09-19
1
No Actions
Case Referred to Mediation - Magistrate Judge only
2016-09-21
1
No Actions
PROPOSED ORDER -- Discovery Confidentiality Order by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Noreika, Maryellen) (Entered: 09/29/2016)
2016-09-29
1
MOTION for Pro Hac Vice Appearance of Attorney Katherine D. Hundt - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 09/30/2016)
2016-09-30
1
SO ORDERED
2016-10-03
1
No Actions
Add Attorneys - PHV only
2016-10-03
1
No Actions
Pro Hac Vice Attorney Katherine D. Hundt for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (klc)
2016-10-03
1
No Actions
SO ORDERED, re 20 MOTION for Pro Hac Vice Appearance of Attorney Katherine D. Hundt filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 10/3/16. (ntl)
2016-10-03
1
No Actions
SO ORDERED
2016-10-04
1
No Actions
SO ORDERED, re 19 DISCOVERY CONFIDENTIALITY ORDER. Signed by Judge Leonard P. Stark on 10/4/16. (ntl)
2016-10-04
1
No Actions
NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Requests for Production to Plaintiffs (Nos. 1-2) filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Noreika, Maryellen) (Entered: 10/06/2016)
2016-10-06
1
NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Noreika, Maryellen) (Entered: 10/10/2016)
2016-10-10
1
NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things to Defendant filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Noreika, Maryellen) (Entered: 10/14/2016)
2016-10-14
1
NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and (2) Plaintiffs' Initial Disclosures Pursuant to Rule 26(a)(1) filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Noreika, Maryellen) (Entered: 10/19/2016)
2016-10-19
1
NOTICE OF SERVICE of 1. Defendant Teva Pharmaceuticals USA, Inc.'s Rule 26(a)(1) Initial Disclosures and 2. Teva Pharmaceuticals USA, Inc.'s Initial Disclosures under Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 10/20/2016)
2016-10-20
1
ORDER Setting Mediation Conference: A Telephone Conference is set for 11/8/2016 at 10:45 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 10/20/2016. (dlk) (Main Document 26 replaced on 10/20/2016) (dlk). (Entered: 10/20/2016)
2016-10-20
1
NOTICE OF SERVICE of 1. Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Requests for Admission to Plaintiffs (Nos. 1-3) 2. Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Interrogatories to Plaintiffs (Nos. 1-9) 3. Defendant Teva Pharmaceuticals USA, Inc.'s Second Request for Production to Plaintiffs (Nos. 3-47) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 11/02/2016)
2016-11-02
1
NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Responses and Objections to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-68) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 11/15/2016)
2016-11-15
1
ORDER Resetting Mediation Conference: A Telephone Conference is set for 12/12/2016 at 11:15 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 11/21/2016. (dlk) (Entered: 11/21/2016)
2016-11-21
1
CLAIM Construction Chart by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibits A-B, # 2 Exhibits C-Q, # 3 Exhibits R-Z)(Noreika, Maryellen) (Entered: 11/22/2016)
2016-11-22
1
NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendant's First Set of Interrogatories to Plaintiffs (Nos. 1-9), (2) Plaintiffs' Objections and Responses to Defendant's Second Request for Production to Plaintiffs (Nos. 3-47) and (3) Plaintiffs' Objections and Responses to Defendant's First Set of Requests for Admission to Plaintiffs (Nos. 1-3) filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Noreika, Maryellen) (Entered: 12/05/2016)
2016-12-05
1
NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Third Request for Production to Plaintiffs No. 48 filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 12/07/2016)
2016-12-07
1
Amended ANSWER to 1 Complaint,, COUNTERCLAIM against Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 12/07/2016)
2016-12-07
1
STIPULATION (and proposed order) for extension of time to serve Initial Invalidity Contentions to December 23, 2016 and to submit Technology Tutorials to January 17, 2017 by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 12/13/2016)
2016-12-13
1
ORDER Setting Mediation Conference: A Telephone Conference is set for 3/13/2017 at 11:00 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 12/15/2016. (dlk) (Entered: 12/15/2016)
2016-12-15
1
[SEALED] CLAIM CONSTRUCTION OPENING BRIEF filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 12/20/2016)
2016-12-20
1
DECLARATION re 36 Claim Construction Opening Brief [DECLARATION OF EDMUND J. ELDER PH.D.] by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 12/20/2016)
2016-12-20
1
[SEALED] APPENDIX re 36 Claim Construction Opening Brief by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Keller, Karen) (Entered: 12/20/2016)
2016-12-20
1
CLAIM CONSTRUCTION OPENING BRIEF filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibits 1-10)(Noreika, Maryellen) (Entered: 12/20/2016)
2016-12-20
1
Joint Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding Request for a Discovery Teleconference. (Keller, Karen) (Entered: 12/22/2016)
2016-12-22
1
SO ORDERED
2016-12-22
1
No Actions
SO ORDERED re 34 Stipulation for extension of time to serve Initial Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 12/22/16. (etg)
2016-12-22
1
No Actions
NOTICE OF SERVICE of Defendant's Initial Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 12/27/2016)
2016-12-27
1
REDACTED VERSION of 36 Claim Construction Opening Brief by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 12/27/2016)
2016-12-27
1
REDACTED VERSION of 38 Appendix,, by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Part 2 of 6, # 2 Part 3 of 6, # 3 Part 4 of 6, # 4 Part 5 of 6, # 5 Part 6 of 6)(Keller, Karen) (Entered: 12/27/2016)
2016-12-27
1
ANSWER to 33 Answer to Complaint, Counterclaim -- Plaintiff's Answer to Defendant's Amended Counterclaims -- by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Blumenfeld, Jack) (Entered: 12/28/2016)
2016-12-28
1
NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant's Third Request for Production to Plaintiffs (No. 48) filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Noreika, Maryellen) (Entered: 01/06/2017)
2017-01-06
1
STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to January 23, 2017 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 01/09/2017)
2017-01-09
1
SO ORDERED, re 46 STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to January 23, 2017 filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 1/11/17. (ntl)
2017-01-11
1
No Actions
SO ORDERED
2017-01-11
1
No Actions
ORAL ORDER: After having been advised by Plaintiff(s) and Defendant(s) of their inability to resolve a discovery matter, IT IS HEREBY ORDERED that a teleconference is scheduled for February 3, 2017 at 9:45 a.m. Counsel for the party seeking relief shall initiate the teleconference call to 302-573-4571. IT IS FURTHER ORDERED that not later than January 24, 2017, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than January 26, 2017, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Each party shall submit to the Court two (2) courtesy copies of its discovery letter and any attachments. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Leonard P. Stark on 1/13/17. (ntl) (Entered: 01/13/2017)
2017-01-13
1
Order Setting Teleconference
2017-01-13
1
No Actions
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding enclosing technology tutorial. (Noreika, Maryellen) (Entered: 01/17/2017)
2017-01-17
1
Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding Submission of Defendant Teva Pharmaceuticals USA, Inc.'s Technology Tutorial. (Keller, Karen) (Entered: 01/17/2017)
2017-01-17
1
[SEALED] Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding Discovery Dispute - re 47 Order Setting Teleconference,,,,. (Attachments: # 1 Exhibit 1-8)(Keller, Karen) (Entered: 01/24/2017)
2017-01-24
1
REDACTED VERSION of 50 Letter by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 01/26/2017)
2017-01-26
1
[SEALED] Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding infringment contentions - re 50 Letter, 47 Order Setting Teleconference,,,,. (Attachments: # 1 Exhibit A)(Noreika, Maryellen) (Entered: 01/26/2017)
2017-01-26
1
ORAL ORDER: Having reviewed the parties' letters (D.I. 50, 52), IT IS HEREBY ORDERED that Teva's request that Takeda supplement its preliminary infringement contentions is DENIED. Takeda has sufficiently identified its infringement theory and has additionally represented that it will supplement its infringement contentions once its has finished testing recently-obtained product samples. The teleconference scheduled for February 3 is CANCELLED. ORDERED by Judge Leonard P. Stark on 1/31/17. (ntl) (Entered: 01/31/2017)
2017-01-31
1
Order Cancelling Deadline
2017-01-31
1
No Actions
REDACTED VERSION of 52 Letter by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A)(Noreika, Maryellen) (Entered: 02/01/2017)
2017-02-01
1
REDACTED VERSION of 52 Letter by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A)(Noreika, Maryellen) (Entered: 02/01/2017)
2017-02-01
2
STIPULATION TO EXTEND TIME for the parties to file their answering claim construction briefs to March 13, 2017 - filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Noreika, Maryellen) (Entered: 02/24/2017)
2017-02-24
1
SO ORDERED, re 55 STIPULATION TO EXTEND TIME for the parties to file their answering claim construction briefs to March 13, 2017 filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 2/27/17. (ntl)
2017-02-27
1
No Actions
SO ORDERED
2017-02-27
1
No Actions
STIPULATION of Dismissal of Action with Prejudice by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.. (Noreika, Maryellen) (Entered: 03/14/2017)
2017-03-14
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) SEE REPORT. (ntl) (Entered: 03/15/2017)
2017-03-15
1
SO ORDERED, re 56 Stipulation of Dismissal filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 3/15/17. (ntl)
2017-03-15
1
No Actions
~Util - Terminate Civil Case AND SO ORDERED
2017-03-15
1
No Actions